ADVANCED HEPATOCELLULAR CARCINOMA
Clinical trials for ADVANCED HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug shows promise in liver cancer fight
Disease control CompletedThis study tested a drug called itacitinib in 19 adults with advanced liver cancer that had not responded to first treatment. The drug works by blocking a protein that helps cancer spread. The main goals were to check safety and see if tumors shrank. Results help guide future res…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: Imperial College London • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Liver cancer drug shows promise in late-stage trial
Disease control CompletedThis study tested the drug sorafenib in 50 adults with advanced liver cancer that could not be removed by surgery and had worsened after at least one prior treatment. The goal was to see how long the cancer stayed under control and to check for side effects. Results help doctors …
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Bo Hyun Kim • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New drug combo shows promise for Tough-to-Treat liver cancer
Disease control CompletedThis study tested a combination of two drugs—futibatinib (which blocks cancer cell growth) and pembrolizumab (which helps the immune system attack cancer)—in 14 adults with advanced or spreading liver cancer that had not responded to prior treatment. The goal was to see if the co…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New PET scan could sharpen view of advanced liver cancer
Diagnosis CompletedThis study tested whether a special PET scan using a radioactive tracer (68Ga-PSMA) can improve how doctors see and manage advanced liver cancer that has spread. The tracer attaches to a protein found on liver cancer cells, making them show up on the scan. 29 adults with advanced…
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated May 15, 2026 11:57 UTC
-
Liver cancer study reveals which organs respond best to drug combo
Knowledge-focused CompletedThis study looked at 131 people with advanced liver cancer to see how a combination of two drugs (atezolizumab and bevacizumab) affects tumors in different parts of the body. The goal was to understand why some tumors shrink and others don't, especially in the liver. Researchers …
Matched conditions: ADVANCED HEPATOCELLULAR CARCINOMA
Sponsor: CHA University • Aim: Knowledge-focused
Last updated May 04, 2026 16:17 UTC